Active 0 6 0 6 O
ALL 7 10 7 10 O
in 11 13 11 13 O
the 14 17 14 17 O
central 18 25 18 25 B-chronic_disease
nervous 26 33 26 33 I-chronic_disease
system 34 40 34 40 I-chronic_disease
( 41 42 41 42 I-chronic_disease
CNS 42 45 42 45 I-chronic_disease
) 45 46 45 46 I-chronic_disease
, 46 47 46 47 O
as 48 50 48 50 O
defined 51 58 51 58 O
by 59 61 59 61 O
> 62 63 62 63 O
/= 63 65 63 65 O
5 66 67 66 67 B-lower_bound
leukocytes 68 78 68 78 I-lower_bound
per 79 82 79 82 I-lower_bound
microL 83 89 83 89 I-lower_bound
with 90 94 90 94 O
identifiable 95 107 95 107 O
blast 108 113 108 113 O
cells 114 119 114 119 O
in 120 122 120 122 O
the 123 126 123 126 O
CSF 127 130 127 130 O
, 130 131 130 131 O
and/or 132 138 132 138 O
the 139 142 139 142 O
presence 143 151 143 151 O
of 152 154 152 154 O
cranial 155 162 155 162 B-chronic_disease
- 162 163 162 163 I-chronic_disease
nerve 163 168 163 168 I-chronic_disease
palsies 169 176 169 176 I-chronic_disease

Medications 0 11 177 188 O
for 12 15 189 192 O
GVHD 16 20 193 197 B-chronic_disease
prophylaxis 21 32 198 209 I-chronic_disease

Patients 0 8 210 218 O
1 9 10 219 220 B-lower_bound
- 10 11 220 221 O
70 11 13 221 223 B-upper_bound
years 14 19 224 229 I-upper_bound
of 20 22 230 232 O
age 23 26 233 236 B-age

Patients 0 8 237 245 O
with 9 13 246 250 O
B 14 15 251 252 B-cancer
- 15 16 252 253 I-cancer
lineage 16 23 253 260 I-cancer

Performance 0 11 261 272 B-clinical_variable
status 12 18 273 279 I-clinical_variable
of 19 21 280 282 O
0 22 23 283 284 B-lower_bound
, 23 24 284 285 O
1 25 26 286 287 O
, 26 27 287 288 O
or 28 30 289 291 O
2 31 32 292 293 B-upper_bound

Pregnant 0 8 294 302 B-pregnancy

Relapsed 0 8 303 311 O
ALL 9 12 312 315 O
defined 13 20 316 323 O
as 21 23 324 326 O
> 24 25 327 328 O
5 25 26 328 329 B-lower_bound
% 26 27 329 330 I-lower_bound
malignant 28 37 331 340 O
blasts 38 44 341 347 O
in 45 47 348 350 O
bone 48 52 351 355 O
marrow 53 59 356 362 O
or 60 62 363 365 O
peripheral 63 73 366 376 O
blood 74 79 377 382 O

Uncontrolled 0 12 383 395 B-chronic_disease
disease 13 20 396 403 I-chronic_disease
/ 20 21 403 404 I-chronic_disease
infection 21 30 404 413 I-chronic_disease
as 31 33 414 416 O
judged 34 40 417 423 O
by 41 43 424 426 O
the 44 47 427 430 O
treating 48 56 431 439 O
physician 57 66 440 449 O

any 0 3 450 453 O
residual 4 12 454 462 B-cancer
disease 13 20 463 470 I-cancer
defined 21 28 471 478 O
by 29 31 479 481 O
positive 32 40 482 490 B-clinical_variable
flow 41 45 491 495 I-clinical_variable
> 46 47 496 497 O
0.01 47 51 497 501 B-lower_bound
% 51 52 501 502 I-lower_bound
, 52 53 502 503 O
detection 54 63 504 513 O
of 64 66 514 516 O
BCR 67 70 517 520 B-clinical_variable
- 70 71 520 521 I-clinical_variable
ABL 71 74 521 524 I-clinical_variable
transcript 75 85 525 535 O
by 86 88 536 538 O
PCR 89 92 539 542 B-treatment
with 93 97 543 547 O
a 98 99 548 549 O
sensitivity 100 111 550 561 O
of 112 114 562 564 O
1/10,000 115 123 565 573 O
, 123 124 573 574 O
or 125 127 575 577 O
detection 128 137 578 587 O
of 138 140 588 590 O
the 141 144 591 594 O
t(9;22 145 151 595 601 O
) 151 152 601 602 O
translocation 153 166 603 616 O
in 167 169 617 619 O
any 170 173 620 623 O
metaphases 174 184 624 634 O
by 185 187 635 637 O
cytogenetics 188 200 638 650 O
at 201 203 651 653 O
time 204 208 654 658 O
of 209 211 659 661 O
transplant 212 222 662 672 B-treatment
, 222 223 672 673 O
or 224 226 674 676 O
presence 227 235 677 685 O
of 236 238 686 688 O
the 239 242 689 692 O
MLL 243 246 693 696 B-clinical_variable
gene 247 251 697 701 I-clinical_variable

patients 0 8 702 710 O
beyond 9 15 711 717 O
CR1 16 19 718 721 B-cancer
or 20 22 722 724 O
with 23 27 725 729 O
primary 28 35 730 737 O
induction 36 45 738 747 O
failure 46 53 748 755 O
may 54 57 756 759 O
be 58 60 760 762 O
without 61 68 763 770 O
minimal 69 76 771 778 B-cancer
residual 77 85 779 787 I-cancer
disease 86 93 788 795 I-cancer

